- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Unresectable Locally Advanced or Metastatic Cancer
Total 1936 results
-
Centre Leon BerardBayerActive, not recruitingMetastatic Cancer | Solid Tumor, Adult | Locally Advanced Solid TumorFrance
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...RecruitingLocally Advanced, Recurrent or Metastatic MalignanciesChina
-
Ascenta TherapeuticsTerminatedLocally Advanced Esophageal or GE Junction CancerUnited States
-
NKGen Biotech, Inc.Active, not recruitingMetastatic Cancer | Advanced Solid Tumor | Advanced Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer | Unresectable CarcinomaUnited States
-
R-PharmCompletedMetastatic Breast Cancer | Triple Negative Locally Advanced Non-resectable Breast CancerCzech Republic, Italy, Poland, Spain, Austria, France, Greece
-
ImmunityBio, Inc.Active, not recruitingSolid Tumor | Metastatic Cancer | Locally Advanced Solid TumorUnited States
-
OSI PharmaceuticalsCompletedLocally Advanced or Metastatic Adenoca of the Biliary TractUnited States, Belgium, Germany, Poland, Romania, Switzerland
-
Tyligand Bioscience (Shanghai) LimitedRecruitingHas a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or LymphomaChina
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
Herlev HospitalActive, not recruitingBorderline Resectable, Locally Advanced or Metastatic Pancreatic CancerDenmark
-
AstraZenecaActive, not recruitingLocally Advanced or Metastatic Solid TumoursUnited States, Spain, Canada, Korea, Republic of
-
Institut BergoniéMinistry of Health, France; PharmaMarTerminatedAdult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated LiposarcomaFrance
-
BJ Bioscience, Inc.Merck Sharp & Dohme LLC; PPDActive, not recruitingLocally Advanced/Metastatic Solid TumorsUnited States
-
Merck Sharp & Dohme LLCCompletedLocally Advanced, Metastatic Solid Tumors
-
National Cancer Institute (NCI)CompletedStage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Pleomorphic Liposarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Metastatic Unresectable Sarcoma | Unresectable Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma | Locally Advanced Soft Tissue Sarcoma | Metastatic... and other conditionsUnited States
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingLocally Advanced or Metastatic Breast CancerChina
-
Fudan UniversityNot yet recruitingBreast Neoplasms | Locally Advanced or Metastatic Breast Cancer
-
Sun Yat-sen UniversityChengdu Biostar PharmaceuticalsNot yet recruitingBreast Neoplasms | Locally Advanced or Metastatic Breast CancerChina
-
Genor Biopharma Co., Ltd.RecruitingLocally Advanced or Metastatic Breast CancerChina
-
Eisai Korea Inc.CompletedLocally Advanced or Metastatic Breast CancerKorea, Republic of
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Xuanzhu Biopharmaceutical Co., Ltd.RecruitingLocally Advanced or Metastatic Solid Tumors | Locally Advanced or Metastatic Non-small Cell Lung CancerChina
-
National Cancer Institute (NCI)SuspendedLocally Advanced Leiomyosarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Locally Advanced Liposarcoma | Locally Advanced Undifferentiated Pleomorphic Sarcoma | Locally Advanced Extraskeletal Myxoid Chondrosarcoma | Locally Advanced Unresectable Soft Tissue SarcomaUnited States, Canada
-
Seoul National University HospitalSeoul National University Bundang Hospital; SMG-SNU Boramae Medical CenterActive, not recruitingLocally Advanced or Metastatic NSCLCKorea, Republic of
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of, China, Japan
-
Suzhou Forlong Biotechnology Co.,Ltd,Active, not recruitingLocally Advanced/Metastatic Solid TumorsUnited States
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.Active, not recruitingLocally Advanced or Metastatic NSCLCChina
-
Mohammed M MilhemGenentech, Inc.CompletedSarcoma | Soft Tissue Sarcoma | Metastatic Sarcoma | Locally Advanced Sarcoma | Unresectable SarcomaUnited States
-
Bio-Thera SolutionsRecruitingLocally Advanced/Metastatic Solid TumoursChina
-
Centre Antoine LacassagneRecruitingMetastatic or Locally-advanced Digestive CancerFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Locally Advanced Bladder Urothelial Carcinoma | Locally Advanced Renal Pelvis Urothelial... and other conditionsUnited States
-
Sichuan UniversityUnknownMetastatic Gastric Cancer | Gastroesophageal Junction Adenocarcinoma | Stomach Adenocarcinoma | Locally Advanced Unresectable Gastric AdenocarcinomaChina
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerSpain, Denmark, United States, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Canada, China, India, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, Brazil, Poland, Sweden, Italy
-
Faeth TherapeuticsRecruitingMetastatic Pancreatic Adenocarcinoma | Locally Advanced Unresectable Pancreatic AdenocarcinomaUnited States
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
Jiangsu Simcere Pharmaceutical Co., Ltd.UnknownAdvanced or Metastatic Gastric Cancer | Advanced or Metastatic CRC | Advanced or Metastatic Liver Cancer | Advanced or Metastatic Non Squamous NSCLCChina
-
Karyopharm Therapeutics IncActive, not recruitingLocally Advanced Unresectable or Metastatic MelanomaUnited States
-
OncoMed Pharmaceuticals, Inc.TerminatedMetastatic Cancer | Locally Advanced Malignant NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedLocally Advanced Epithelioid Hemangioendothelioma | Metastatic Epithelioid Hemangioendothelioma | Unresectable Epithelioid HemangioendotheliomaUnited States
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingLocally Advanced or Metastatic Breast CancerChina
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, India, Mexico, Germany, Portugal, Spain, Thailand, Turkey, United Kingdom, Kenya, Hungary, Colombia, Oman, Saudi Arabia, Poland, Egypt, U... and more
-
MediLink Therapeutics (Suzhou) Co., Ltd.Active, not recruitingLocally Advanced or Metastatic Breast CancerChina
-
Sermonix Pharmaceuticals Inc.Linical Accelovance GroupActive, not recruitingLocally Advanced or Metastatic Breast CancerUnited States, Canada, Israel
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.Italy, Spain, United Kingdom, Sweden, Japan, Netherlands, Germany, France
-
Tianjin Medical University Cancer Institute and...Active, not recruitingPotentially Resectable Locally Advanced Malignant Tumors of Biliary SystemChina
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsUnknownAdvanced and/or Metastatic Solid Organ CancerUnited States
-
Sun Yat-sen UniversityHunan Cancer Hospital; Beijing Biostar Pharmaceuticals Co., Ltd.RecruitingBreast Neoplasms | Locally Advanced or Metastatic Breast CancerChina
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced orKorea, Republic of
-
Regione LombardiaMario Negri Institute for Pharmacological Research; Istituto Clinico HumanitasUnknownMetastatic or Locally Advanced Breast CancerItaly